Loma Linda Cancer Center

Loma Linda, California 92354

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Transitional Cell, Non-Small Cell Lung Cancer, Transitional Cell Carcinoma of Renal Pelvis

Studies at this site

• The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study — Completed
• A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) — Completed
• Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy — NO_LONGER_AVAILABLE